Quantum-Si (NASDAQ:QSI) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Quantum-Si (NASDAQ:QSIFree Report) in a research note released on Friday morning, Benzinga reports. The brokerage currently has a $4.00 target price on the stock. HC Wainwright also issued estimates for Quantum-Si’s Q1 2025 earnings at ($0.22) EPS, Q2 2025 earnings at ($0.21) EPS, Q3 2025 earnings at ($0.20) EPS and Q4 2025 earnings at ($0.20) EPS.

Quantum-Si Stock Up 1.2 %

Quantum-Si stock opened at $1.72 on Friday. The business has a 50-day simple moving average of $1.78 and a 200 day simple moving average of $1.69. Quantum-Si has a 52 week low of $1.12 and a 52 week high of $3.90. The stock has a market cap of $243.84 million, a price-to-earnings ratio of -2.65 and a beta of 3.04.

Quantum-Si (NASDAQ:QSIGet Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.09. Quantum-Si had a negative net margin of 7,145.76% and a negative return on equity of 30.44%. The company had revenue of $0.46 million for the quarter, compared to analysts’ expectations of $0.45 million. During the same period in the prior year, the business earned ($0.17) earnings per share. On average, research analysts anticipate that Quantum-Si will post -0.87 earnings per share for the current year.

Insider Transactions at Quantum-Si

In other news, CFO Jeffry R. Keyes acquired 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were bought at an average cost of $1.61 per share, with a total value of $80,500.00. Following the acquisition, the chief financial officer now owns 50,000 shares in the company, valued at approximately $80,500. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Quantum-Si news, CFO Jeffry R. Keyes bought 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were bought at an average price of $1.61 per share, for a total transaction of $80,500.00. Following the transaction, the chief financial officer now directly owns 50,000 shares in the company, valued at $80,500. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jeffrey Alan Hawkins purchased 25,000 shares of the stock in a transaction on Thursday, March 14th. The stock was acquired at an average cost of $1.76 per share, with a total value of $44,000.00. Following the completion of the purchase, the chief executive officer now directly owns 25,000 shares of the company’s stock, valued at $44,000. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 85,000 shares of company stock valued at $141,900. Insiders own 30.04% of the company’s stock.

Hedge Funds Weigh In On Quantum-Si

A number of large investors have recently bought and sold shares of QSI. Vanguard Group Inc. increased its stake in shares of Quantum-Si by 1.6% in the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after buying an additional 82,463 shares during the period. Bleakley Financial Group LLC bought a new stake in Quantum-Si in the 1st quarter worth $28,000. Simplicity Wealth LLC purchased a new position in shares of Quantum-Si in the first quarter valued at about $28,000. TIG Advisors LLC bought a new position in shares of Quantum-Si during the fourth quarter valued at about $166,000. Finally, General American Investors Co. Inc. boosted its holdings in shares of Quantum-Si by 146.8% during the fourth quarter. General American Investors Co. Inc. now owns 294,350 shares of the company’s stock worth $592,000 after purchasing an additional 175,100 shares during the period. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

Featured Stories

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.